Почетна › Немалоклетни карцином плућа › Њујорк › Rochester

Kliničke studije za Немалоклетни карцином плућа u gradu Rochester, NY

13 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Rochester i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Тражи се учесникФаза 2/3

Rochester General Hospital Infectious Disease, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07100080

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Тражи се учесникФаза 3

Wilmot Cancer Institute ( Site 0141), Rochester

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07190248

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3

Rochester General Hospital, Rochester
University of Rochester, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Тражи се учесникФаза 3

University of Rochester Medical Center, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06216301

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Тражи се учесникФаза 3

University of Rochester Medical Center, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06561386

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2

University of Rochester, Rochester

18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3

University of Rochester, Rochester
Wilmot Cancer Institute at Webster, Webster · 10 ми удаљено

Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Тражи се учесникФаза 3

Research Site, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT06868277

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Тражи се учесникФаза 3

University of Rochester, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT06686771

Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

Тражи се учесникЗдраве особе су добродошле

University of Rochester, Rochester

Узраст 60 и старији · Оба пола · Ажурирано 8. 7. 2026. · NCT06139627

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Тражи се учесникФаза 1

University of Rochester, Rochester
University of Rochester, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 4. 6. 2026. · NCT04297605

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2

University of Rochester, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

Тражи се учесникФаза 2

University of Rochester, Rochester

Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2025. · NCT06262321

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Rochester

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.